16 kDa のカタセプシン D 分割型プロラクチンは,産後心筋病を媒介するプロラクチンです
関連する実験動画
Updated: Jul 17, 2026

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Denise Hilfiker-Kleiner1, Karol Kaminski, Edith Podewski
1Department of Cardiology and Angiology, MHH, 30625 Hannover, Germany. hilfiker.denise@mh-hannover.de
Cell
|February 10, 2007
まとめ
産後心筋病症 (PPCM) は,プロラクチン誘導体に関連しています. プロラクチン放出を阻害することは,新しいPPCM治療戦略を提供することができる.
科学分野:
- 心血管生物学 心血管生物学
- エンドクリノロジー エンドクリノロジー
- 分子医学は分子医学である.
背景:
- 産後心筋病変 (PPCM) は,原因不明の深刻な心疾患であり,出産後の女性の死亡リスクが高い.
- PPCMの病因は未だに曖昧であり,その根本的なメカニズムに関する研究が必要である.
研究 の 目的:
- PPCMの発達における信号トランスデューサーとトランスクリプション3のアクティベーター (STAT3) の役割を調査する.
- プロラクチンとキャセプシンD (CD) の関与を調査することによって,PPCMの潜在的な治療標的を特定する.
主な方法:
- PPCMの発達を研究するために,心筋細胞特異的なSTAT3の削除を伴うマウスモデルを使用しました.
- 評価された心臓のキャセプシンD (CD) の発現と活性,および16 kDaのプロラクチン断片の生成.
- ブロモクリプチン (プロラクチン阻害剤) の作用と,マウスにおける16 kDaのプロラクチンの強制的な心筋生成を調査した.
- 心筋組織におけるSTAT3タンパク質レベルと,PPCM患者における活性化されたCDと16 kDaのプロラクチンの血清レベルを分析した.
主要な成果:
- PPCMを誘発した雌マウスのSTAT3の心臓筋細胞特異的デリレーション.
- 心臓CD発現と活性が強化され,プロアポプトティックな16 kDaのプロラクチン断片が生成されました.
- ブロモクリプチンの治療は,マウスのPPCM発症を予防しました.
- 心筋のSTAT3濃度が低下し,PPCM患者では血清CDと16 kDaのプロラクチンが上昇した.
結論:
- プロラクチン16 kDaの生物学的活性派生体がPPCMを媒介する.
- PPCM患者では心筋STAT3の減少,血清CDと16 kDaのプロラクチン値の上昇が観察されています.
- プロラクチン放出の抑制は,PPCMのための潜在的な新しい治療戦略を表しています.
関連する概念動画
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

